Literature DB >> 2360255

Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model.

C Féray1, A L Zignego, D Samuel, A Bismuth, M Reynes, P Tiollais, H Bismuth, C Brechot.   

Abstract

We have investigated the recurrence of Hepatitis B virus (HBV) in 30 patients treated by orthotopic liver transplantation and given high doses of anti-HBs immunoglobulin. The polymerase chain reaction (PCR) assay showed no evidence of HBV DNA sequences in the liver of 23/24 patients who remained serum HBsAg-negative during a mean follow-up of 13 months (2-24 months) after OLT. However, the liver scored positive in all the 6 individuals in whom HBsAG reappeared. The PCR assay identified HBV DNA sequences in the peripheral blood mononuclear cells of 7 of 11 subjects who were serum HBsAG-negative and liver HBV DNA-negative by PCR. Therefore, this application of the sensitive PCR assay demonstrates persistent infection of PBMC in the absence of liver HBV--thus OLT provides a model for studying the interaction between HBV, PBMC, and the liver.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360255     DOI: 10.1097/00007890-199006000-00025

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  22 in total

Review 1.  Hepatitis B virus infection in liver transplant candidates and recipients.

Authors:  Patrick Yachimski; Raymond T Chung
Journal:  MedGenMed       Date:  2005-04-18

2.  Hepatitis B virus infection and liver transplantation.

Authors:  N A Terrault; T L Wright
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

3.  Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.

Authors:  C S Coffin; P M Mulrooney-Cousins; M G Peters; G van Marle; J P Roberts; T I Michalak; N A Terrault
Journal:  J Viral Hepat       Date:  2011-06       Impact factor: 3.728

4.  Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients.

Authors:  S Stoll-Becker; R Repp; D Glebe; S Schaefer; J Kreuder; M Kann; F Lampert; W H Gerlich
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.

Authors:  Fabrizio Marcucci; Enea Spada; Alfonso Mele; Carmelo Antonio Caserta; Alessandro Pulsoni
Journal:  Am J Blood Res       Date:  2012-01-01

6.  Liver transplantation for hepatocellular carcinoma.

Authors:  J McPeake; R Williams
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

Review 7.  Viral markers in the treatment of hepatitis B and C.

Authors:  H Schmilovitz-Weiss; M Levy; N Thompson; G Dusheiko
Journal:  Gut       Date:  1993       Impact factor: 23.059

Review 8.  Controversies in patient selection for liver transplantation.

Authors:  E B Keeffe; C O Esquivel
Journal:  West J Med       Date:  1993-11

Review 9.  Polymerase chain reaction for the diagnosis of viral hepatitis B and C.

Authors:  C Bréchot
Journal:  Gut       Date:  1993       Impact factor: 23.059

10.  In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus.

Authors:  Y Y Lew; T I Michalak
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.